Vitrivax Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Vitrivax General Information

Description

Developer of formulation of thermostable vaccines designed to eliminate barriers to global vaccination. The company offers a proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology platform to enable thermostable, single-shot vaccines across a broad range of indications while maintaining or potentially even enhancing the immune response of vaccines, enabling users to incorporate prime doses and additional booster doses in a single-shot administration.

Contact Information

Website
www.vitrivaxbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5435 Airport Boulevard
  • Suite 106
  • Boulder, CO 80301
  • United States
+1 (720)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
AgTech, HealthTech
Corporate Office
  • 5435 Airport Boulevard
  • Suite 106
  • Boulder, CO 80301
  • United States
+1 (720)

Vitrivax Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitrivax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 06-Dec-2023 Completed Generating Revenue
3. Later Stage VC (Series A) 10-Apr-2023 Completed Generating Revenue
2. Later Stage VC (Series A) 07-Dec-2020 $7.5M $7.5M Completed Generating Revenue
1. Grant 22-May-2020 $240K Completed Generating Revenue
To view Vitrivax’s complete valuation and funding history, request access »

Vitrivax Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Vitrivax’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vitrivax Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Vitrivax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4486932-A1 Chemical vapor deposition device with adherence disruption feature and methods of using the same Pending 04-Mar-2022
US-20250051913-A1 Chemical vapor deposition device with adherence disruption feature and methods of using the same Pending 04-Mar-2022
JP-2025507980-A Chemical vapor deposition device with adhesion breaking capability and method of use thereof Pending 04-Mar-2022 C23C16/45544

Vitrivax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitrivax Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gates Foundation Not-For-Profit Venture Capital
Buff Gold Ventures Venture Capital Minority
Fox Ventures Corporate Venture Capital Minority
New Day Venture Capital Venture Capital Minority
Adjuvant Capital Impact Investing Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Vitrivax FAQs

  • When was Vitrivax founded?

    Vitrivax was founded in 2014.

  • Where is Vitrivax headquartered?

    Vitrivax is headquartered in Boulder, CO.

  • What is the size of Vitrivax?

    Vitrivax has 41 total employees.

  • What industry is Vitrivax in?

    Vitrivax’s primary industry is Discovery Tools (Healthcare).

  • Is Vitrivax a private or public company?

    Vitrivax is a Private company.

  • What is Vitrivax’s current revenue?

    The current revenue for Vitrivax is .

  • How much funding has Vitrivax raised over time?

    Vitrivax has raised $8.8M.

  • Who are Vitrivax’s investors?

    Gates Foundation, Buff Gold Ventures, Fox Ventures, New Day Venture Capital, and Adjuvant Capital are 5 of 9 investors who have invested in Vitrivax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »